CD8A and babesiosis: In accordance with the above-mentioned findings, we set out to investigate the quantities of CD4+ and CD8+ bovine T cells during the course of Babesia infection and enumerate them during our new culture-derived attenuated live vaccine trial as a hallmark of protection [52].